116 related articles for article (PubMed ID: 19114898)
1. The thiazolidinedione ciglitazone reduces bacterial outgrowth and early inflammation during Streptococcus pneumoniae pneumonia in mice.
Stegenga ME; Florquin S; de Vos AF; van der Poll T
Crit Care Med; 2009 Feb; 37(2):614-8. PubMed ID: 19114898
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae.
Phipps JC; Aronoff DM; Curtis JL; Goel D; O'Brien E; Mancuso P
Infect Immun; 2010 Mar; 78(3):1214-20. PubMed ID: 20008540
[TBL] [Abstract][Full Text] [Related]
3. Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock.
Chima RS; Hake PW; Piraino G; Mangeshkar P; Denenberg A; Zingarelli B
Crit Care Med; 2008 Oct; 36(10):2849-57. PubMed ID: 18828195
[TBL] [Abstract][Full Text] [Related]
4. Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice.
de Stoppelaar SF; Van't Veer C; van den Boogaard FE; Nieuwland R; Hoogendijk AJ; de Boer OJ; Roelofs JJ; van der Poll T
Thromb Haemost; 2013 Sep; 110(3):582-92. PubMed ID: 23783078
[TBL] [Abstract][Full Text] [Related]
5. Mucin 1 protects against severe Streptococcus pneumoniae infection.
Dhar P; Ng GZ; Dunne EM; Sutton P
Virulence; 2017 Nov; 8(8):1631-1642. PubMed ID: 28605238
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of importance of Toll-like receptor 4 in acute Streptococcus pneumoniae sinusitis in mice.
Luxameechanporn T; Kirtsreesakul V; Klemens J; Khoury P; Thompson K; Naclerio RM
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):1001-6. PubMed ID: 16301373
[TBL] [Abstract][Full Text] [Related]
7. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
Xu Q; Surendran N; Verhoeven D; Klapa J; Ochs M; Pichichero ME
Vaccine; 2015 Feb; 33(8):993-1000. PubMed ID: 25597944
[TBL] [Abstract][Full Text] [Related]
8. Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia.
van den Boogaard FE; van 't Veer C; Roelofs JJ; Meijers JC; Schultz MJ; Broze GJ; van der Poll T
Thromb Haemost; 2015 Jul; 114(1):115-22. PubMed ID: 25832548
[TBL] [Abstract][Full Text] [Related]
9. Kinetic study of the inflammatory response in Streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004.
Duong M; Simard M; Bergeron Y; Bergeron MG
Antimicrob Agents Chemother; 2001 Jan; 45(1):252-62. PubMed ID: 11120974
[TBL] [Abstract][Full Text] [Related]
10. DNAX-activating protein of 12 kDa impairs host defense in pneumococcal pneumonia.
Hommes TJ; Hoogendijk AJ; Dessing MC; Van't Veer C; Florquin S; de Vos AF; van der Poll T
Crit Care Med; 2014 Dec; 42(12):e783-90. PubMed ID: 25402298
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice.
Tavares LP; Garcia CC; Vago JP; Queiroz-Junior CM; Galvão I; David BA; Rachid MA; Silva PM; Russo RC; Teixeira MM; Sousa LP
Am J Respir Cell Mol Biol; 2016 Jul; 55(1):24-34. PubMed ID: 26677751
[TBL] [Abstract][Full Text] [Related]
12. Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia.
Schouten M; van 't Veer C; Roelofs JJ; Gerlitz B; Grinnell BW; Levi M; van der Poll T
Thromb Haemost; 2011 Dec; 106(6):1189-96. PubMed ID: 21901240
[TBL] [Abstract][Full Text] [Related]
13. Dectin-2-dependent host defense in mice infected with serotype 3 Streptococcus pneumoniae.
Akahori Y; Miyasaka T; Toyama M; Matsumoto I; Miyahara A; Zong T; Ishii K; Kinjo Y; Miyazaki Y; Saijo S; Iwakura Y; Kawakami K
BMC Immunol; 2016 Jan; 17():1. PubMed ID: 26727976
[TBL] [Abstract][Full Text] [Related]
14. Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia.
Hommes TJ; van Lieshout MH; van 't Veer C; Florquin S; Bootsma HJ; Hermans PW; de Vos AF; van der Poll T
PLoS One; 2015; 10(12):e0145138. PubMed ID: 26673231
[TBL] [Abstract][Full Text] [Related]
15. Cytosolic Phospholipase A
Bhowmick R; Clark S; Bonventre JV; Leong JM; McCormick BA
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808157
[TBL] [Abstract][Full Text] [Related]
16. Microbial exposure early in life regulates airway inflammation in mice after infection with Streptococcus pneumoniae with enhancement of local resistance.
Yasuda Y; Matsumura Y; Kasahara K; Ouji N; Sugiura S; Mikasa K; Kita E
Am J Physiol Lung Cell Mol Physiol; 2010 Jan; 298(1):L67-78. PubMed ID: 19783640
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae.
Kerr AR; Wei XQ; Andrew PW; Mitchell TJ
Microb Pathog; 2004 Jun; 36(6):303-10. PubMed ID: 15120156
[TBL] [Abstract][Full Text] [Related]
18. Leptin corrects host defense defects after acute starvation in murine pneumococcal pneumonia.
Mancuso P; Huffnagle GB; Olszewski MA; Phipps J; Peters-Golden M
Am J Respir Crit Care Med; 2006 Jan; 173(2):212-8. PubMed ID: 16210671
[TBL] [Abstract][Full Text] [Related]
19. Characterization of S. pneumoniae pneumonia-induced multiple organ dysfunction syndrome: an experimental mouse model of gram-positive sepsis.
Andonegui G; Goring K; Liu D; McCafferty DM; Winston BW
Shock; 2009 Apr; 31(4):423-8. PubMed ID: 18827750
[TBL] [Abstract][Full Text] [Related]
20. PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease.
Ramos-Sevillano E; Urzainqui A; de Andrés B; González-Tajuelo R; Domenech M; González-Camacho F; Sánchez-Madrid F; Brown JS; García E; Yuste J
PLoS Pathog; 2016 Mar; 12(3):e1005500. PubMed ID: 26975045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
